DK172633B1 - Fremgangsmåde til fremstilling af en FeLV-vaccine og sammensætning og vaccine omfattende en således fremstillet inaktiveret - Google Patents

Fremgangsmåde til fremstilling af en FeLV-vaccine og sammensætning og vaccine omfattende en således fremstillet inaktiveret Download PDF

Info

Publication number
DK172633B1
DK172633B1 DK198906310A DK631089A DK172633B1 DK 172633 B1 DK172633 B1 DK 172633B1 DK 198906310 A DK198906310 A DK 198906310A DK 631089 A DK631089 A DK 631089A DK 172633 B1 DK172633 B1 DK 172633B1
Authority
DK
Denmark
Prior art keywords
vaccine
inactivated
preparing
produced
composition
Prior art date
Application number
DK198906310A
Other languages
Danish (da)
English (en)
Other versions
DK631089A (da
DK631089D0 (da
Inventor
Edward A Hoover
James I Mullins
Original Assignee
Univ Harvard
Univ Colorado State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Harvard, Univ Colorado State Res Found filed Critical Univ Harvard
Publication of DK631089D0 publication Critical patent/DK631089D0/da
Publication of DK631089A publication Critical patent/DK631089A/da
Application granted granted Critical
Publication of DK172633B1 publication Critical patent/DK172633B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13061—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198906310A 1988-12-13 1989-12-13 Fremgangsmåde til fremstilling af en FeLV-vaccine og sammensætning og vaccine omfattende en således fremstillet inaktiveret DK172633B1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28413988A 1988-12-13 1988-12-13

Publications (3)

Publication Number Publication Date
DK631089D0 DK631089D0 (da) 1989-12-13
DK631089A DK631089A (da) 1990-06-14
DK172633B1 true DK172633B1 (da) 1999-03-22

Family

ID=23088994

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906310A DK172633B1 (da) 1988-12-13 1989-12-13 Fremgangsmåde til fremstilling af en FeLV-vaccine og sammensætning og vaccine omfattende en således fremstillet inaktiveret

Country Status (12)

Country Link
US (1) US6042835A (fr)
EP (2) EP0699758B1 (fr)
JP (1) JP3164351B2 (fr)
AT (2) ATE128730T1 (fr)
AU (2) AU4616289A (fr)
CA (1) CA2005311C (fr)
DE (2) DE68924478T2 (fr)
DK (1) DK172633B1 (fr)
ES (2) ES2084596T3 (fr)
GR (1) GR3018587T3 (fr)
IE (1) IE74875B1 (fr)
NZ (1) NZ231744A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901778D0 (en) * 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
IL104382A0 (en) * 1992-01-17 1993-05-13 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant
GB9210337D0 (en) * 1992-05-14 1992-07-01 Univ Court Of The University O Feline leukaemia virus vaccine
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
JP4303315B2 (ja) 1994-05-09 2009-07-29 オックスフォード バイオメディカ（ユーケー）リミテッド 非交差性レトロウイルスベクター
US7674618B2 (en) 2003-09-04 2010-03-09 Medarex, Inc. Expression vector
ZA200608178B (en) * 2004-03-30 2008-10-29 Roussy Inst Gustave Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
MX351642B (es) * 2011-07-20 2017-10-23 Merial Ltd Vacuna para virus de leucemia felina recombinante que contiene gen de envoltura del virus de leucemia felina optimizado.
WO2018152097A1 (fr) 2017-02-16 2018-08-23 Bio-Rad Laboratories, Inc. Nouvelles transcriptases inverses et leurs utilisations

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034081A (en) * 1973-09-18 1977-07-05 University Of Glasgow Vaccines against feline leukemia
GB1486186A (en) * 1973-09-18 1977-09-21 Univ Glasgow Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom
US4264587A (en) * 1979-08-01 1981-04-28 Pedersen Niels C Vaccine for preventing persistent feline leukemia viremia in cats
US4332793A (en) * 1979-12-18 1982-06-01 The Ohio State University Research Foundation Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom
US4434157A (en) * 1979-12-18 1984-02-28 The Ohio State University Research Foundation Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
EP0156299A3 (fr) * 1984-03-26 1987-04-01 Chiron Corporation Vaccins viraux à LTR modifié
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4789702A (en) * 1984-05-18 1988-12-06 Cetus Corporation Feline leukemia virus vaccine
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
AU607399B2 (en) * 1985-09-09 1991-03-07 Cetus Corporation Infectious recombinant virus vaccine for feline leukemia
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
PT84976B (pt) * 1986-05-30 1990-02-08 Cambridge Bioscience Corp Metodo para a producao de antigenios de virus de leucemia felina contendo polipeptideos recombinantes
GB2197321B (en) * 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
EP0262887A3 (fr) * 1986-10-03 1989-07-26 Bayer Corporation Lignée de cellules de félin infectées par FeLV
US5306493A (en) * 1986-10-03 1994-04-26 Miles Inc. FeLV-infected feline cell line
JPH01501939A (ja) * 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
AU612404B2 (en) * 1987-09-11 1991-07-11 Genentech Inc. Method for increasing the expression of polypeptides in recombinant cell culture

Also Published As

Publication number Publication date
IE893974L (en) 1990-06-13
IE960745L (en) 1990-06-13
ES2179854T3 (es) 2003-02-01
IE74875B1 (en) 1997-08-13
JP3164351B2 (ja) 2001-05-08
ES2084596T3 (es) 1996-05-16
US6042835A (en) 2000-03-28
DE68924478D1 (de) 1995-11-09
DE68924478T2 (de) 1996-03-07
DK631089A (da) 1990-06-14
JPH03117490A (ja) 1991-05-20
GR3018587T3 (en) 1996-04-30
CA2005311C (fr) 2006-05-30
ATE221119T1 (de) 2002-08-15
EP0377842A1 (fr) 1990-07-18
CA2005311A1 (fr) 1990-06-13
EP0699758A1 (fr) 1996-03-06
DE68929419T2 (de) 2003-04-03
EP0699758B1 (fr) 2002-07-24
AU3710493A (en) 1993-07-15
ATE128730T1 (de) 1995-10-15
DE68929419D1 (de) 2002-08-29
EP0377842B1 (fr) 1995-10-04
AU4616289A (en) 1990-06-21
DK631089D0 (da) 1989-12-13
AU661134B2 (en) 1995-07-13
NZ231744A (en) 1993-01-27

Similar Documents

Publication Publication Date Title
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
NO863803L (no) Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids).
DK33190D0 (da) Hiv-3 retrovirus og anvendelse heraf
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
DK172633B1 (da) Fremgangsmåde til fremstilling af en FeLV-vaccine og sammensætning og vaccine omfattende en således fremstillet inaktiveret
ATE365206T1 (de) Verfahren zur entwicklung von einem hiv impfstoff
ATE103328T1 (de) Fuer ein glykoprotein des aids-virus kodierende virus-vektoren, vakzin und antikoerper.
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
FI885296A0 (fi) Rekombinant hiv-2 polypeptid.
ES2070846T3 (es) Arn-virus sin reversion.
EP1136562A3 (fr) Vaccins contre le virus de la leucémie féline
DK76688D0 (da) Vaccine indeholdende f-proteinet fra aids-virus
SE9202934D0 (sv) Vacciner mot melanom
DK1418941T3 (da) Induktion af immunrespons mod felint immundefektvirus
FI893346A0 (fi) Icke-reverterande rna-virus.
HK167295A (en) Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens
ATE126702T1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired